ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation

21 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Private Placement of $18.9 Million

15 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update

14 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial

08 Nov 2022 07:00:03 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022

31 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

27 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Fall Investor Conferences

07 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update

11 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022

28 Jul 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

01 Jul 2022 15:05:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation

29 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference

21 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users

01 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at LD Micro Invitational Conference

26 May 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

13 May 2022 07:00:00 By Nasdaq GlobeNewswire

Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update

12 May 2022 15:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

27 Apr 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022

21 Apr 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

15 Mar 2022 07:00:02 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award

11 Mar 2022 07:00:00 By Nasdaq GlobeNewswire